Myriad Genetics' Crescendo Bioscience Offers New Clinical Data on Vectra(R) DA at ACR

By: via Benzinga
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq: MYGN), today presented new data that showed Vectra^® ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.